Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05288166
What this trial is testing

Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisUrogenital Neoplasms+14 more
Eli Lilly and Company 925
Testing effectiveness (Phase 2)Looking for participantsNCT06506643
What this trial is testing

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

Who this might be right for
CLLSolid Tumor, Adult
Vector Vitale LLC 36
Not applicableStudy completedNCT01091883
What this trial is testing

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Who this might be right for
Bone CancerBone MetastasesPain
InSightec 60
Not applicableLooking for participantsNCT06469710
What this trial is testing

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

Who this might be right for
Prostate CancerCirculating Tumor CellLeukapheresis
RenJi Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT02065323
What this trial is testing

Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr.
Testing effectiveness (Phase 2)Looking for participantsNCT01913106
What this trial is testing

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 25
Not applicableStudy completedNCT02518698
What this trial is testing

Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population

Who this might be right for
Prostate Cancer
Bayer 1,163
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Not applicableStudy completedNCT03223727
What this trial is testing

Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223

Who this might be right for
Prostate Cancer MetastaticBone Metastases
The Netherlands Cancer Institute 100
Not applicableWithdrawnNCT03325127
What this trial is testing

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer
Testing effectiveness (Phase 2)Ended earlyNCT01020305
What this trial is testing

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Sandy Srinivas 5
Not applicableUnknownNCT04967001
What this trial is testing

68Ga-PSMA PET in the Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastasesPSMA-PET
Xijing Hospital 300
Large-scale testing (Phase 3)Looking for participantsNCT06276465
What this trial is testing

Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Who this might be right for
Prostatic Cancer, Castration-Resistant
UNICANCER 336
Not applicableStudy completedNCT02156414
What this trial is testing

Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer

Who this might be right for
Secondary Malignant Neoplasm of Lymph NodeProstatic Neoplasms
Javeriana University 135
Not applicableStudy completedNCT07306767
What this trial is testing

Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH

Who this might be right for
Benign Prostatic HyperplasiaLower Urinary Tract SymptomsBladder Outlet Obstruction
Ain Shams University 130
Not applicableStudy completedNCT03496844
What this trial is testing

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
University of Arizona 15
Early research (Phase 1)Study completedNCT00108264
What this trial is testing

Tumor RNA Transfected Dendritic Cell Vaccines

Who this might be right for
Prostate Cancer
US Department of Veterans Affairs
Testing effectiveness (Phase 2)WithdrawnNCT02054793
What this trial is testing

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Emmanuel Antonarakis, MD
Testing effectiveness (Phase 2)Looking for participantsNCT05422911
What this trial is testing

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Who this might be right for
Metastatic CancerNeoplasm, ProstateCastrate-sensitive+1 more
Sun Pharmaceutical Industries Limited 192
Testing effectiveness (Phase 2)Looking for participantsNCT06347705
What this trial is testing

2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 57
Next Page